PR000356 (Project)

Dcc Asset:

MW submission packet 20260310.zip

Processed File (Entity type)

Dcc:

Metabolomics

DCC (Entity type)

Child Project:

PPR00001

Project (Entity type)

Persistent Id:http://dx.doi.org/10.21228/M81K5Z

Description:Pulmonary arterial hypertension (PAH) is a progressive and incurable disease characterized by obliteration of the pulmonary arterioles, elevated pulmonary vascular resistance (PVR), and eventual right heart failure and death. Current medical therapy for PAH is aimed at reducing PVR by targeting pathways involved in vasodilation. Pulmonary vasodilators improve functional capacity but do not target the underlying vascular obstruction. Despite multiple approved therapies, median survival after diagnosis is less than five years, indicating that additional therapeutic targets are needed.

Results found

Linked to

	Label	Description
	SA023429 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023488 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023424 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023506 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023466 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023539 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023554 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023477 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023552 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project
	SA023546 Biosample (Entity type)	A biosample from Metabolomics produced as part of the PR000356 project